Inhaler, aerosol, portable
Access comprehensive regulatory information for Inhaler, aerosol, portable in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by GlaxoSmithKline Australia Pty Ltd, manufactured by GSK Consumer Healthcare (GMDT) in Ireland. The device registration started on April 01, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The Haleraid is a device designed to place over the GlaxoSmithKline range of metered dose inhalers as an aid to operation by patients with impaired strength in their hands (e.g. arthritis). Specifically for use with GlaxoSmithKline's 120 Dose and 200 Dose metered dose inhalars (MDI's).